By Maarten Pieter Schinkel & Abel d’Ailly (University of Amsterdam)
Western competition authorities responded quick and united to the COVID-19 pandemic with a generous exemption from cartel law for any companies that aim to solve pressing scarcities in anticompetitive collaboration. However there is little reason to expect more supply, fair distribution, low prices or wider use of personal protective equipment from horizontal collaboration. The agencies should better have stood by competition instead. Embracing the policy might have been about public image, more than high expectations of collaboration amongst rivals contributing to solving the needs associated with COVID-19. That experimental treatment is not without side effects. By relaxing the first article of antitrust, the agencies undermined their authority, just when we need them to effectively control the many markets that are rapidly consolidating, due to the consequences of the lock-downs.
Featured News
Senate Democrats Urge DOJ Investigation into Alleged Big Oil Collusion
May 30, 2024 by
CPI
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI